AFAR in the News: SuperAgers Family Study PI Sofiya Milman, MD, MS, featured in The New York Times
![AFAR in the News: SuperAgers Family Study PI Sofiya Milman, MD, MS, featured in The New York Times]()
On August 7th, 2025, The New York Times published an article focusing on exceptional longevity and SuperAgers. AFAR SuperAgers Family Study Principal Investigator Sofiya Milman, MD, MS, provided insights into factors that could influence SuperAgers’ longevity. Along with genetics, Dr. Milman highlighted how resilience and positive attitudes could impact who will thrive well into their 100s.
The SuperAgers Family Study, led by AFAR in collaboration with the Albert Einstein College of Medicine and the Boston University School of Medicine, aims to collect data from a large group of individuals who have lived to age 95 or more. The Study's goal is to understand and uncover the biological factors contributing to healthy aging and exceptional longevity shared among SuperAgers and their families.
Learn more and enroll in the SuperAgers Family Study here.
Dr. Milman is a 2012 AFAR Postdoctoral Fellow and a 2015 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. She is the Director of Human Longevity Studies at the Institute for Aging Research at Albert Einstein College of Medicine as well as the Principal Investigator of the AFAR SuperAgers Family Study.
Read the article “The One Quality Most ‘Super-Agers’ Share” here.